Angiotensin II-induced changes of calcium sparks and ionic currents in human atrial myocytes: Potential role for early remodeling in atrial fibrillation

被引:69
作者
Gassanov, N
Brandt, MC
Michels, G
Lindner, M
Er, F
Hoppe, UC
机构
[1] Univ Cologne, Dept Internal Med 3, D-50937 Cologne, Germany
[2] Univ Cologne, CMMC, Ctr Mol Med, D-5000 Cologne 41, Germany
关键词
angiotensin; atrial fibrillation; ionic currents; calcium sparks; remodeling;
D O I
10.1016/j.ceca.2005.10.008
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: Atrial angiotensin II (ANG II) levels have been shown to be increased in atrial fibrillation (AF). The purpose of the study was to evaluate a potential role of ANG II in the early remodeling and susceptibility to chronicization of AF. Methods and results: Isolated human atrial myocytes were incubated in ANG II and/or angiotensin type 1 receptor blocker candesartan. ANG II markedly increased the frequency of spontaneous Ca2+ sparks, spark full duration, time to peak Ca2+ fluorescence and decay time measured by confocal imaging. Sarcoplasmic reticulum calcium content estimated by caffeine-evoked calcium release did not differ between ANG II-treated cells and controls. Patch-clamp recordings revealed that ANG II significantly decreased I-to and increased I-Ca,I-L current densities. Candesartan blocked these ANG II-mediated alterations. ANG II exhibited no effect on I-KI, I-Kur and I-f current size. Expression of connexin 40 and connexin 43 was not significantly changed by ANG II as assessed by immunohistochemistry and Western blot analysis. Conclusion: ANG II-induced alterations of calcium handling and electrophysiological changes inhuman atrial cells similar to those previously observed in the onset of AF. Prevention of these alterations by candesartan might constitute a useful pharmacological strategy for the treatment of AF. (C) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:175 / 186
页数:12
相关论文
共 62 条
[31]   Effect of bilateral nephrectomy on active renin, angiotensinogen, and renin glycoforms in plasma and myocardium [J].
Katz, SA ;
Opsahl, JA ;
Lunzer, MM ;
Forbis, LM ;
Hirsch, AT .
HYPERTENSION, 1997, 30 (02) :259-266
[32]   Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure [J].
Li, DS ;
Shinagawa, K ;
Pang, L ;
Leung, TK ;
Cardin, S ;
Wang, ZG ;
Nattel, S .
CIRCULATION, 2001, 104 (21) :2608-2614
[33]   Calcium sparks in human ventricular cardiomyocytes from patients with terminal heart failure [J].
Lindner, M ;
Brandt, MC ;
Sauer, H ;
Hescheler, J ;
Böhle, T ;
Beuckelmann, DJ .
CELL CALCIUM, 2002, 31 (04) :175-182
[34]  
Lipsius SL, 2001, NEWS PHYSIOL SCI, V16, P101
[35]   Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation [J].
Nakashima, H ;
Kumagai, K ;
Urata, H ;
Gondo, N ;
Ideishi, M ;
Arakawa, K .
CIRCULATION, 2000, 101 (22) :2612-2617
[36]   Comparison of expression of connexin in right atrial myocardium in patients with chronic atrial fibrillation versus those in sinus rhythm [J].
Nao, T ;
Ohkusa, T ;
Hisamatsu, Y ;
Inoue, N ;
Matsumoto, T ;
Yamada, J ;
Shimizu, A ;
Yoshiga, Y ;
Yamagata, T ;
Kobayashi, S ;
Yano, M ;
Hamano, K ;
Matsuzaki, M .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (06) :678-683
[37]   Therapeutic implications of atrial fibrillation mechanisms: can mechanistic insights be used to improve AF management? [J].
Nattel, S .
CARDIOVASCULAR RESEARCH, 2002, 54 (02) :347-360
[38]   New ideas about atrial fibrillation 50 years on [J].
Nattel, S .
NATURE, 2002, 415 (6868) :219-226
[39]  
Pogwizd SM, 1999, CIRC RES, V85, P1009
[40]   Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria [J].
Polontchouk, L ;
Haefliger, JA ;
Ebelt, B ;
Schaefer, T ;
Stuhlmann, D ;
Mehlhorn, U ;
Kuhn-Regnier, F ;
De Vivie, ER ;
Dhein, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (03) :883-891